174 related articles for article (PubMed ID: 21375762)
1. Prevention of hypertension in patients with pre-hypertension: protocol for the PREVER-prevention trial.
Fuchs FD; Fuchs SC; Moreira LB; Gus M; Nóbrega AC; Poli-de-Figueiredo CE; Mion D; Bortoloto L; Consolim-Colombo F; Nobre F; Coelho EB; Vilela-Martin JF; Moreno H; Cesarino EJ; Franco R; Brandão AA; de Sousa MR; Ribeiro AL; Jardim PC; Neto AA; Scala LC; Mota M; Chaves H; Alves JG; Filho DC; Pereira e Silva R; Neto JA; Irigoyen MC; Castro I; Steffens AA; Schlatter R; de Mello RB; Mosele F; Ghizzoni F; Berwanger O
Trials; 2011 Mar; 12():65. PubMed ID: 21375762
[TBL] [Abstract][Full Text] [Related]
2. A comparison between diuretics and angiotensin-receptor blocker agents in patients with stage I hypertension (PREVER-treatment trial): study protocol for a randomized double-blind controlled trial.
Fuchs FD; Fuchs SC; Moreira LB; Gus M; Nóbrega AC; Poli-de-Figueiredo CE; Mion D; Bortolotto L; Consolim-Colombo F; Nobre F; Coelho EB; Vilela-Martin JF; Moreno H; Cesarino EJ; Franco R; Brandão AA; de Sousa MR; Ribeiro AL; Jardim PC; Afiune Neto A; Scala LC; Mota M; Chaves H; Alves JG; Sobral Filho DC; Pereira e Silva R; Figueiredo Neto JA; Irigoyen MC; Castro I; Steffens AA; Schlatter R; de Mello RB; Mosele F; Ghizzoni F; Berwanger O
Trials; 2011 Feb; 12():53. PubMed ID: 21349192
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of Chlorthalidone Plus Amiloride for the Prevention of Hypertension: The PREVER-Prevention Randomized Clinical Trial.
Fuchs SC; Poli-de-Figueiredo CE; Figueiredo Neto JA; Scala LC; Whelton PK; Mosele F; de Mello RB; Vilela-Martin JF; Moreira LB; Chaves H; Mota Gomes M; de Sousa MR; Silva RP; Castro I; Cesarino EJ; Jardim PC; Alves JG; Steffens AA; Brandão AA; Consolim-Colombo FM; de Alencastro PR; Neto AA; Nóbrega AC; Franco RS; Sobral Filho DC; Bordignon A; Nobre F; Schlatter R; Gus M; Fuchs FC; Berwanger O; Fuchs FD
J Am Heart Assoc; 2016 Dec; 5(12):. PubMed ID: 27965209
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of low-dose diuretics for blood pressure reduction to optimal values in prehypertension: a randomized clinical trial.
Fuchs FD; Fuchs SC; Poli-de-Figueiredo CE; Figueiredo Neto JA; Scala LCN; Vilela-Martin JF; Moreira LB; Chaves H; Mota Gomes M; de Sousa MR; Silva RPE; Castro I; Cesarino EJ; Sousa ALL; Alves JG; Steffens AA; Brandão AA; Bortolotto LA; Afiune Neto A; Nóbrega AC; Franco RS; Sobral Filho DC; Nobre F; Schlatter R; Gus M; De David CN; Rafaelli L; Sesin GP; Berwanger O; Whelton PK
J Hypertens; 2018 Apr; 36(4):933-938. PubMed ID: 29227377
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of chlorthalidone and hydrochlorothiazide in combination with amiloride in multiple doses on blood pressure in patients with primary hypertension: a protocol for a factorial randomized controlled trial.
Martins VM; Helal L; Ferrari F; Bottino LG; Fuchs SC; Fuchs FD
Trials; 2019 Dec; 20(1):736. PubMed ID: 31843024
[TBL] [Abstract][Full Text] [Related]
6. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group.
JAMA; 2000 Apr; 283(15):1967-75. PubMed ID: 10789664
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of chlorthalidone/amiloride versus losartan in patients with stage I hypertension and diabetes mellitus: results from the PREVER-treatment randomized controlled trial.
Fuchs FD; Scala LCN; Vilela-Martin JF; Whelton PK; Poli-de-Figueiredo CE; Pereira E Silva R; Gus M; Bortolotto LA; Consolim-Colombo FM; Schlatter RP; Cesarino JE; Castro I; Figueiredo Neto JA; Chaves H; Steffens AA; Alves JG; Brandão AA; de Sousa MR; Jardim PC; Moreira LB; Franco RS; Gomes MM; Afiune Neto A; Fuchs FC; Sobral Filho DC; Nóbrega AC; Nobre F; Berwanger O; Fuchs SC
Acta Diabetol; 2021 Feb; 58(2):215-220. PubMed ID: 33047257
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of chlorthalidone/amiloride versus losartan in patients with stage I hypertension: results from the PREVER-treatment randomized trial.
Fuchs FD; Scala LC; Vilela-Martin JF; de Mello RB; Mosele F; Whelton PK; Poli-de-Figueiredo CE; de Alencastro PR; E Silva RP; Gus M; Bortolotto LA; Schlatter R; Cesarino EJ; Castro I; Neto JA; Chaves H; Steffens AA; Alves JG; Brandão AA; de Sousa MR; Jardim PC; Moreira LB; Franco RS; Gomes MM; Neto AA; Fuchs FC; Filho DC; Nóbrega AC; Nobre F; Berwanger O; Fuchs SC
J Hypertens; 2016 Apr; 34(4):798-806. PubMed ID: 26938814
[TBL] [Abstract][Full Text] [Related]
9. Prehypertension: the rationale for early drug therapy.
Fuchs FD
Cardiovasc Ther; 2010 Dec; 28(6):339-43. PubMed ID: 20553286
[TBL] [Abstract][Full Text] [Related]
10. Echocardiographic Left Ventricular Reverse Remodeling After 18 Months of Antihypertensive Treatment in Stage I Hypertension. Results From the Prever-Treatment Study.
Bertoluci C; Foppa M; Santos ABS; Branchi TV; Fuchs SC; Fuchs FD
Am J Hypertens; 2018 Feb; 31(3):321-328. PubMed ID: 29036504
[TBL] [Abstract][Full Text] [Related]
11. The effect of antihypertensive agents on sleep apnea: protocol for a randomized controlled trial.
Cichelero FT; Martinez D; Fuchs SC; Gus M; Moreira LB; Fuchs FD
Trials; 2014 Jan; 15():1. PubMed ID: 24382030
[TBL] [Abstract][Full Text] [Related]
12. Diuretics are Similar to Losartan on Echocardiographic Target-Organ Damage in Stage I Hypertension. PREVER-Treatment Study.
Bertoluci C; Foppa M; Santos ABS; Fuchs SC; Fuchs FD
Arq Bras Cardiol; 2019 Jan; 112(1):87-90. PubMed ID: 30673020
[TBL] [Abstract][Full Text] [Related]
13. S-amlodipine plus chlorthalidone vs. S-amlodipine plus telmisartan in hypertensive patients unresponsive to amlodipine monotherapy: study protocol for a randomized controlled trial.
Jo SH; Park SJ; Kim EJ; Kim SJ; Cho HJ; Song JM; Shin J; Park JJ; Shin JH; Han KR; Choi DJ
Trials; 2018 Jun; 19(1):324. PubMed ID: 29925421
[TBL] [Abstract][Full Text] [Related]
14. Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group.
Curb JD; Pressel SL; Cutler JA; Savage PJ; Applegate WB; Black H; Camel G; Davis BR; Frost PH; Gonzalez N; Guthrie G; Oberman A; Rutan GH; Stamler J
JAMA; 1996 Dec; 276(23):1886-92. PubMed ID: 8968014
[TBL] [Abstract][Full Text] [Related]
15. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
JAMA; 2002 Dec; 288(23):2981-97. PubMed ID: 12479763
[TBL] [Abstract][Full Text] [Related]
16. Combination of amlodipine plus angiotensin receptor blocker or diuretics in high-risk hypertensive patients: a 96-week efficacy and safety study.
Ma L; Wang W; Zhao Y; Zhang Y; Deng Q; Liu M; Sun H; Wang J; Liu L
Am J Cardiovasc Drugs; 2012 Apr; 12(2):137-42. PubMed ID: 22329591
[TBL] [Abstract][Full Text] [Related]
17. Effects of blood pressure lowering on outcome incidence in hypertension: 4. Effects of various classes of antihypertensive drugs--overview and meta-analyses.
Thomopoulos C; Parati G; Zanchetti A
J Hypertens; 2015 Feb; 33(2):195-211. PubMed ID: 25485720
[TBL] [Abstract][Full Text] [Related]
18. Effect of antihypertensive agents on sleep apnea and ambulatory blood pressure in patients with hypertension: A randomized controlled trial.
Cichelero FT; Fuchs SC; Jorge JA; Martinez D; Oliveira GPF; Lucca MB; Oliveira ACT; Fuchs FD
Sleep Med; 2024 Jul; 119():417-423. PubMed ID: 38781664
[TBL] [Abstract][Full Text] [Related]
19. Do thiazide diuretics reduce central systolic blood pressure in hypertension?
Yugar LBT; Moreno B; Moreno H; Vilela-Martin JF; Yugar-Toledo JC
J Clin Hypertens (Greenwich); 2018 Jan; 20(1):133-135. PubMed ID: 29106774
[No Abstract] [Full Text] [Related]
20. Role of diuretics in the prevention of heart failure: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.
Davis BR; Piller LB; Cutler JA; Furberg C; Dunn K; Franklin S; Goff D; Leenen F; Mohiuddin S; Papademetriou V; Proschan M; Ellsworth A; Golden J; Colon P; Crow R;
Circulation; 2006 May; 113(18):2201-10. PubMed ID: 16651474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
